Betaferon Prospective Study on Adherence, Coping and Nursing Support.
Phase of Trial: Phase IV
Latest Information Update: 17 Sep 2016
At a glance
- Drugs Interferon beta-1b (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- Acronyms BEACON
- Sponsors Bayer
- 20 Jan 2014 According to ClinicalTrials.gov record, status changed from active, no longer recruiting to completed.
- 28 Oct 2013 Planned end date changed from 1 Oct 2013 to 1 Nov 2013 as reported by ClinicalTrials.gov.
- 01 Aug 2013 Planned number of patients changed from 1500 to 1722 as reported by ClinicalTrials.gov.